API | Acoziborole

Acoziborole Report issue

Small molecule Experimental

AACT DrugBank MeSH PubChem

Active Ingredient History

NOW

Chemistry

SMILES: CC1(C)OB(O)c2cc(NC(=O)c3ccc(F)cc3C(F)(F)F)ccc21
InChIKey: PTYGDEXEGLDNAZ-UHFFFAOYSA-N
Mol. Mass: 367.11
ALogP: Missing data
ChEMBL Molecule:
acoziborole

More Chemistry

Pharmacology

Mechanisms of Action:
- Cleavage and polyadenylation specificity factor subunit (Trypanosoma brucei equiperdum) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

scyx7158 | scyx 7158 | scyx-7158

Organizations (3)

Research & Development (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (6)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (6)

Infections (Phase 2/Phase 3)

Parasitic Diseases (Phase 1)

Protozoan Infections (Phase 1)

Sleep Disorders, Intrinsic (Phase 2/Phase 3)

Trypanosomiasis (Phase 2/Phase 3)

Trypanosomiasis, African (Phase 2/Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 6
# of Trial Organizations: 3

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue